<!doctype html><html lang=en dir=auto><head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1313&amp;path=livereload" data-no-instant defer></script><meta charset=utf-8><meta http-equiv=X-UA-Compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1,shrink-to-fit=no"><meta name=robots content="index, follow"><title>Projects | Hang Li</title>
<meta name=keywords content><meta name=description content="Projects - Hang Li"><meta name=author content="Hang Li"><link rel=canonical href=http://localhost:1313/projects/><meta name=google-site-verification content="XYZabc"><meta name=yandex-verification content="XYZabc"><meta name=msvalidate.01 content="XYZabc"><link crossorigin=anonymous href=/assets/css/stylesheet.038f37ff6b5676c48525d1fecec4b00e87f1d0a2126a5ed477aa6382ac995064.css integrity="sha256-A483/2tWdsSFJdH+zsSwDofx0KISal7Ud6pjgqyZUGQ=" rel="preload stylesheet" as=style><link rel=icon href=http://localhost:1313/favicon.ico><link rel=icon type=image/png sizes=16x16 href=http://localhost:1313/favicon-16x16.png><link rel=icon type=image/png sizes=32x32 href=http://localhost:1313/favicon-32x32.png><link rel=apple-touch-icon href=http://localhost:1313/apple-touch-icon.png><link rel=mask-icon href=http://localhost:1313/safari-pinned-tab.svg><meta name=theme-color content="#2e2e33"><meta name=msapplication-TileColor content="#2e2e33"><link rel=alternate type=application/rss+xml href=http://localhost:1313/projects/index.xml><link rel=alternate hreflang=en href=http://localhost:1313/projects/><noscript><style>#theme-toggle,.top-link{display:none}</style><style>@media(prefers-color-scheme:dark){:root{--theme:rgb(29, 30, 32);--entry:rgb(46, 46, 51);--primary:rgb(218, 218, 219);--secondary:rgb(155, 156, 157);--tertiary:rgb(65, 66, 68);--content:rgb(196, 196, 197);--code-block-bg:rgb(46, 46, 51);--code-bg:rgb(55, 56, 62);--border:rgb(51, 51, 51)}.list{background:var(--theme)}.list:not(.dark)::-webkit-scrollbar-track{background:0 0}.list:not(.dark)::-webkit-scrollbar-thumb{border-color:var(--theme)}}</style></noscript><meta property="og:url" content="http://localhost:1313/projects/"><meta property="og:site_name" content="Hang Li"><meta property="og:title" content="Projects"><meta property="og:description" content="Welcome to the website of **Hang Li**! ðŸš€ CS student, problem solver, and full-time tinkerer. ***Stay curious, stay relentless.***"><meta property="og:locale" content="en-us"><meta property="og:type" content="website"><meta name=twitter:card content="summary"><meta name=twitter:title content="Projects"><meta name=twitter:description content="Welcome to the website of **Hang Li**! ðŸš€ CS student, problem solver, and full-time tinkerer. ***Stay curious, stay relentless.***"><script type=application/ld+json>{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Projects","item":"http://localhost:1313/projects/"}]}</script></head><body class=list id=top><script>localStorage.getItem("pref-theme")==="dark"?document.body.classList.add("dark"):localStorage.getItem("pref-theme")==="light"?document.body.classList.remove("dark"):window.matchMedia("(prefers-color-scheme: dark)").matches&&document.body.classList.add("dark")</script><header class=header><nav class=nav><div class=logo><a href=http://localhost:1313/ accesskey=h title="Hang Li (Alt + H)"><img src=http://localhost:1313/images/coding.png alt aria-label=logo height=27>Hang Li</a><div class=logo-switches><button id=theme-toggle accesskey=t title="(Alt + T)"><svg id="moon" width="24" height="18" viewBox="0 0 24 24" fill="none" stroke="currentcolor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M21 12.79A9 9 0 1111.21 3 7 7 0 0021 12.79z"/></svg><svg id="sun" width="24" height="18" viewBox="0 0 24 24" fill="none" stroke="currentcolor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><circle cx="12" cy="12" r="5"/><line x1="12" y1="1" x2="12" y2="3"/><line x1="12" y1="21" x2="12" y2="23"/><line x1="4.22" y1="4.22" x2="5.64" y2="5.64"/><line x1="18.36" y1="18.36" x2="19.78" y2="19.78"/><line x1="1" y1="12" x2="3" y2="12"/><line x1="21" y1="12" x2="23" y2="12"/><line x1="4.22" y1="19.78" x2="5.64" y2="18.36"/><line x1="18.36" y1="5.64" x2="19.78" y2="4.22"/></svg></button></div></div><ul id=menu><li><a href=http://localhost:1313/blogs/ title=Blogs><span>Blogs</span></a></li><li><a href=http://localhost:1313/projects/ title=Projects><span class=active>Projects</span></a></li><li><a href=http://localhost:1313/infographics/ title=Infographics><span>Infographics</span></a></li><li><a href=http://localhost:1313/about/ title=About><span>About</span></a></li></ul></nav></header><main class=main><header class=page-header><div class=breadcrumbs><a href=http://localhost:1313/>Home</a></div><h1>Projects</h1></header><article class=post-entry><header class=entry-header><h2 class=entry-hint-parent>Towards reproducible computational drug discovery</h2></header><div class=entry-content><p>Abstract The reproducibility of experiments has been a long standing impediment for further scientific progress. Computational methods have been instrumental in drug discovery efforts owing to its multifaceted utilization for data collection, pre-processing, analysis and inference. This article provides an in-depth coverage on the reproducibility of computational drug discovery. This review explores the following topics: (1) the current state-of-the-art on reproducible research, (2) research documentation (e.g. electronic laboratory notebook, Jupyter notebook, etc.), (3) science of reproducible research (i.e. comparison and contrast with related concepts as replicability, reusability and reliability), (4) model development in computational drug discovery, (5) computational issues on model development and deployment, (6) use case scenarios for streamlining the computational drug discovery protocol. In computational disciplines, it has become common practice to share data and programming codes used for numerical calculations as to not only facilitate reproducibility, but also to foster collaborations (i.e. to drive the project further by introducing new ideas, growing the data, augmenting the code, etc.). It is therefore inevitable that the field of computational drug design would adopt an open approach towards the collection, curation and sharing of data/code.
...</p></div><footer class=entry-footer><span title='2022-04-06 23:15:00 +0700 +0700'>April 6, 2022</span>&nbsp;Â·&nbsp;1 min&nbsp;Â·&nbsp;Hang Li</footer><a class=entry-link aria-label="post link to Towards reproducible computational drug discovery" href=http://localhost:1313/projects/reproducible-computational-drug-discovery/></a></article><article class=post-entry><header class=entry-header><h2 class=entry-hint-parent>ERpred: a web server for the prediction of subtype-specific estrogen receptor antagonists</h2></header><div class=entry-content><p>Abstract Estrogen receptors alpha and beta (ERÎ± and ERÎ²) are responsible for breast cancer metastasis through their involvement of clinical outcomes. Estradiol and hormone replacement therapy targets both ERs, but this often leads to an increased risk of breast and endometrial cancers as well as thromboembolism. A major challenge is posed for the development of compounds possessing ER subtype specificity. Herein, we present a large-scale classification structure-activity relationship (CSAR) study of inhibitors from the ChEMBL database which consisted of an initial set of 11,618 compounds for ERÎ± and 7,810 compounds for ERÎ². The IC50 was selected as the bioactivity unit for further investigation and after the data curation process, this led to a final data set of 1,593 and 1,281 compounds for ERÎ± and ERÎ², respectively. We employed the random forest (RF) algorithm for model building and of the 12 fingerprint types, models built using the PubChem fingerprint was the most robust (Ac of 94.65% and 92.25% and Matthews correlation coefficient (MCC) of 89% and 76% for ERÎ± and ERÎ², respectively) and therefore selected for feature interpretation. Results indicated the importance of features pertaining to aromatic rings, nitrogen-containing functional groups and aliphatic hydrocarbons. Finally, the model was deployed as the publicly available web server called ERpred at http://codes.bio/erpred where users can submit SMILES notation as the input query for prediction of the bioactivity against ERÎ± and ERÎ².
...</p></div><footer class=entry-footer><span title='2022-04-05 23:15:00 +0700 +0700'>April 5, 2022</span>&nbsp;Â·&nbsp;2 min&nbsp;Â·&nbsp;Hang Li</footer><a class=entry-link aria-label="post link to ERpred: a web server for the prediction of subtype-specific estrogen receptor antagonists" href=http://localhost:1313/projects/erpred/></a></article><article class=post-entry><header class=entry-header><h2 class=entry-hint-parent>Probing the origins of human acetylcholinesterase inhibition via QSAR modeling and molecular docking</h2></header><div class=entry-content><p>Abstract Alzheimerâ€™s disease (AD) is a chronic neurodegenerative disease which leads to the gradual loss of neuronal cells. Several hypotheses for AD exists (e.g., cholinergic, amyloid, tau hypotheses, etc.). As per the cholinergic hypothesis, the deficiency of choline is responsible for AD; therefore, the inhibition of AChE is a lucrative therapeutic strategy for the treatment of AD. Acetylcholinesterase (AChE) is an enzyme that catalyzes the breakdown of the neurotransmitter acetylcholine that is essential for cognition and memory. A large non-redundant data set of 2,570 compounds with reported IC50 values against AChE was obtained from ChEMBL and employed in quantitative structure-activity relationship (QSAR) study so as to gain insights on their origin of bioactivity. AChE inhibitors were described by a set of 12 fingerprint descriptors and predictive models were constructed from 100 different data splits using random forest. Generated models afforded R2, Q2CV and Q2Ext values in ranges of 0.66â€“0.93, 0.55â€“0.79 and 0.56â€“0.81 for the training set, 10-fold cross-validated set and external set, respectively. The best model built using the substructure count was selected according to the OECD guidelines and it afforded R2, Q2CV and Q2Ext values of 0.92 Â± 0.01, 0.78 Â± 0.06 and 0.78 Â± 0.05, respectively. Furthermore, Y-scrambling was applied to evaluate the possibility of chance correlation of the predictive model. Subsequently, a thorough analysis of the substructure fingerprint count was conducted to provide informative insights on the inhibitory activity of AChE inhibitors. Moreover, Kennardâ€“Stone sampling of the actives were applied to select 30 diverse compounds for further molecular docking studies in order to gain structural insights on the origin of AChE inhibition. Site-moiety mapping of compounds from the diversity set revealed three binding anchors encompassing both hydrogen bonding and van der Waals interaction. Molecular docking revealed that compounds 13, 5 and 28 exhibited the lowest binding energies of âˆ’12.2, âˆ’12.0 and âˆ’12.0 kcal/mol, respectively, against human AChE, which is modulated by hydrogen bonding, Ï€â€“Ï€ stacking and hydrophobic interaction inside the binding pocket. These information may be used as guidelines for the design of novel and robust AChE inhibitors.
...</p></div><footer class=entry-footer><span title='2022-04-04 23:15:00 +0700 +0700'>April 4, 2022</span>&nbsp;Â·&nbsp;2 min&nbsp;Â·&nbsp;Hang Li</footer><a class=entry-link aria-label="post link to Probing the origins of human acetylcholinesterase inhibition via QSAR modeling and molecular docking" href=http://localhost:1313/projects/acetylcholinesterase/></a></article></main><footer class=footer><span>&copy; 2025 <a href=http://localhost:1313/>Hang Li</a></span> Â·
<span>Powered by
<a href=https://gohugo.io/ rel="noopener noreferrer" target=_blank>Hugo</a> &
        <a href=https://github.com/adityatelange/hugo-PaperMod/ rel=noopener target=_blank>PaperMod</a></span></footer><a href=#top aria-label="go to top" title="Go to Top (Alt + G)" class=top-link id=top-link accesskey=g><svg viewBox="0 0 12 6" fill="currentcolor"><path d="M12 6H0l6-6z"/></svg>
</a><script>let menu=document.getElementById("menu");menu&&(menu.scrollLeft=localStorage.getItem("menu-scroll-position"),menu.onscroll=function(){localStorage.setItem("menu-scroll-position",menu.scrollLeft)}),document.querySelectorAll('a[href^="#"]').forEach(e=>{e.addEventListener("click",function(e){e.preventDefault();var t=this.getAttribute("href").substr(1);window.matchMedia("(prefers-reduced-motion: reduce)").matches?document.querySelector(`[id='${decodeURIComponent(t)}']`).scrollIntoView():document.querySelector(`[id='${decodeURIComponent(t)}']`).scrollIntoView({behavior:"smooth"}),t==="top"?history.replaceState(null,null," "):history.pushState(null,null,`#${t}`)})})</script><script>var mybutton=document.getElementById("top-link");window.onscroll=function(){document.body.scrollTop>800||document.documentElement.scrollTop>800?(mybutton.style.visibility="visible",mybutton.style.opacity="1"):(mybutton.style.visibility="hidden",mybutton.style.opacity="0")}</script><script>document.getElementById("theme-toggle").addEventListener("click",()=>{document.body.className.includes("dark")?(document.body.classList.remove("dark"),localStorage.setItem("pref-theme","light")):(document.body.classList.add("dark"),localStorage.setItem("pref-theme","dark"))})</script></body></html>